Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists-Reference-Cited by-同舟云学术

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists

Published:2018-05-10 Issue:8 Volume:57 Page:1432-1438
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Guitton Zelie¹,Terriou Louis¹,Lega Jean-Christophe²,Nove-Josserand Raphaele²,Hie Miguel³,Amoura Zahir³,Bussel James B⁴,Hamidou Mohamed⁵,Rosenthal Eric⁶,Lioger Bertrand⁷,Chauveau Dominique⁸,Chaminade Axel⁹,Magy-Bertrand Nadine¹⁰,Michel Marc¹¹,Audia Sylvain¹²,Godeau Bertrand¹¹,Mahevas Matthieu¹¹

Affiliation:

1. Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France

2. Department of Internal Medecine, CHRU Lyon, Lyon, France

3. Department of Internal Medicine, Pitie-Salpetriere University Hospital, Paris, France

4. Weill Cornell Medicine, New York, NY, USA

5. Department of Internal Medicine, Hôtel Dieu University Hospital, Nantes, France

6. Weill Department of Medicine, Internal Medecine, CHRU Nice, Nice, France

7. Department of Internal Medicine, Bretonneau University Hospital, Tours, France

8. Department of Internal Medicine, CHRU Toulouse, Toulouse, France

9. Hematology, CHRU Réunion, Saint-Pierre, France

10. Internal Medecine, CHRU Besançon, Besançon, France

11. Internal Medicine, French Referral Centre for Adult Immune Cytopenia, Henri Mondor Hospital, AP-HP, UPEC University, Créteil, France

12. Department of Internal Medicine, Dijon University Hospital, Dijon, France

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/57/8/1432/25193899/key119.pdf

Reference37 articles.

1. The diagnosis and management of the haematologic manifestations of lupus;Velo-García;J Autoimmun,2016

2. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus;Petri;Arthritis Rheum,2012

3. Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome;Godeau;Br J Haematol,1997

4. The management of peripheral blood cytopenias in systemic lupus erythematosus;Hepburn;Rheumatology,2010

5. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies;Khellaf;Am J Hematol,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?;Thrombosis Research;2024-09

2. French protocol for the diagnosis and management of systemic lupus erythematosus;La Revue de Médecine Interne;2024-09

3. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study;British Journal of Haematology;2024-03

4. Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management;Expert Review of Hematology;2024-02-19

5. Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes;Research and Practice in Thrombosis and Haemostasis;2024-01